WingA.J., BroyerM., BrunnerF.P.Combined report on regular dialysis and transplantation in Europe, XIII.Proc EDTA1983; 20: 2–76.
2.
JacobsC., BrunnerF.P., BryngerH., ChallahS., KramerP., SelwoodN.H., WingA.J.The first five thousand diabetics treated by dialysis and transplantation in Europe.Diabetic Nephropathy1983; 2: 12–16.
3.
ShapiroF.L., and ComtyC.M.Dialysis of patients with diabetes mellitus. In: MassryS.G., GlassockR.J., eds. Textbook of Nephrology.Baltimore, Williams Wilkins, 1983; pp. 837–841.
4.
MogensenC.E.Blood pressure and diabetic complications: many questions, some answers from a meeting.Diabetic Nephropathy1985; 4: 3–5.
5.
MogensenC.E.Hypertension in diabetes and the stages of diabetic nephropathy.Diabetic Nephropathy1982; 1: 2–7.
6.
MogensenC.E.Long-term antihypertensive treatment inhibiting progression of diabetic nephrooathy.Br Med J1982; 285: 685–688.
7.
ParvingH.H., AndersenA.R., SmidtU.M., SvedsenP.A.Early and aggressive antihypertensive treatment reduces the rate of decline in kidney function in diabetic nephropathy.Lancet1: 1175–1177, 1983.
8.
CatalandS., O'DorisioT.H.Diabetic nephropathy. Clinical course in patients treated with the subcutaneous insulin pump.JAMA1983; 249: 2059–2061.
9.
BjörckS., NybergG., HerlitzH.Granerus G., Mulee H, Aurell M. Captopril treatment of hypertension in diabetic nephropathy.Diabetic Nephropathy1985; 4: 55–56.
10.
NybergG., BlohméG., BjörckS., NordénG.Progression of diabetic nephropathy in relation to plasma glucose control and blood pressure control.Diabetic Nephropathy1985; 4: 53–54.
11.
HasslacherC.Nephropathy in Type I diabetics. Relations to blood pressure and metabolic control.Hypertension (in press).
12.
ChristensenC.K., MogensenC.E.Effect of antihypertensive treatment on progression in incipient diabetic nephropathy.Hypertension (in press).
13.
ParvingH.H., AndersenA.R., SmidtU.M.The effect of long-term antihypertensive treatment on kidney function and albuminuria in diabetic nephropathy.Diabetic Nephropathy1984; 4: 52.
14.
ChristensenC.K., MogensenC.E.Correlations between blood pressure and kidney function in insulin-dependent diabetics: with emphasis on incipient nephropathy.Diabetic Nephropathy1985; 4: 34–40.
15.
FriedmanE.A.Diabetic nephrology is a hyperglycemic glomerulopathy.Arch Intern Med1982; 142: 1269–1270.
16.
RaschR.Prevention of diabetic glomerulopathy in streptozotocin diabetic rats by insulin treatment: glomerular basement membrane thickness.Diabetologia1979; 16: 125–128.
17.
HäggE.Glomerular basement membrane thickening in rats with long-term alloxan diabetes. A quantitative electron microscopic study.Acta Path Microbiol Scand (Section A)1974; 82: 211–219.
18.
SteffesM.W., MauerS.M.Diabetic glomerulopathy: a morphologic approach to monitoring development, progression or reversibility.Diabetic Nephropathy4: 1985; 114–117.
19.
MauerS.M., SteffesM.W., MichaelA.F., BrownD.M.Studies of diabetic nephropathy in animals and man.Diabetes1976; 25: 850–857.
20.
SteffesM.W., BrownD.M., BasgenJ.M., MauerS.M.Amelioration of mesangial volume and surface alterations following islet transplantation in diabetic rats.Diabetes1980; 29: 509–515.
21.
MauerS.M., BrownD.M., MatasA.J., SteffesM.W.Effects of pancreatic islet transplantation on the increased urinary albumin excretion rates in intact and uninephrectomized rats with diabetes mellitus.Diabetes1978; 27: 959–964.
22.
SteffesM.W., BrownD.M., BasgenJ.M., MatasA.J., MauerS.M.Glomerular basement membrane thickness following islet transplantation in the rat.Lab Inv1979; 41: 116–118.
23.
MauerS.M.Understanding and Treatment of Diabetic Nephropathy.New York, Grune & Stratton, Inc., 1981.
24.
AbounaG.M., KremerG.D., DaddahS.K., Al-AdnaniM.S., KumarS.A., KusmaG.Reversal of diabetic nephropathy in human cadaveric kidneys after transplantation into non-diabetic recipients.Lancet1983; 2: 1274–1276.
25.
AllenA.C.Letter to the editor.Lancet1984; 1: 164.
26.
PykeD.A., WatkinsP.J.Letter to the editor.Lancet1984; 1: 163–164.
27.
Deckert T, Lauritzen T, Parving HH, Christiansen JS, and the Steno Study Group.Effect of two years of strict metabolic control on kidney function in long-term insulin-dependent diabetics.Diabetic Nephropathy1983; 2: 6–10.
28.
VibertiG.C., BilousR.W., MackintoshD., BendingJ.J., KeenH.Long term correction of hyperglycemia and progression of renal failure in insulin dependent diabetes.Br Med J1983; 286: 598–602.
29.
McVerryB.A., FisherC., HoppA.Production of pseudodiabetic renal glomerular changes in mice after repeated injections of glycosylated proteins.Lancet1980; 1: 738–740.
30.
Preud'hommeJ.L., Morel-MarogerL., BrouetJ.C.Synthesis of abnormal immunoglobulins in lymphoplasmacytic disorders with visceral light chain deposition.Am J Med1980; 69: 703–710.
31.
BrennerB.M., MeyerT.W., HostetterT.H.Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease.NEJM1982; 307: 632–659.
32.
KlahrS., BuerkertJ., PurkersonM.L.Role of dietary factors in the progression of chronic renal disease.Kidney Int1983; 24: 579–587.
33.
BarsottiG., GiannoniA., MorelliE., LazzeriM., VlamisL., BaldiR., GiovannettiS.The decline of renal function slowed by very low phosphorus intake in chronic renal patients following a low nitrogen diet.Clin Nephrol1984; 21: 54–59.
34.
Diaz-BuxoJ.A., WagonerR.D., HatteryR.R., PalumboP.J.Acute renal failure after excretory urography in diabetic patients.Ann Intern Med1975; 83: 155–158.
35.
ByrdL., ShermanR.L.Radiocontrast-induced acute renal failure. A clinical and pathophysiologic review.Medicine1979; 58: 270–279.
36.
BakrisG.L., BurnettJ.C.Jr.A role for calcium in radiocontrast-induced reductions in renal hemodynamics.Kidney Int1985; 27: 465–468.
37.
TörnquistC., HoltasS.Renal angiography with iohexol and metrizoate.Radiology1984; 150: 331–334.
38.
JabenS., Diaz-BuxoJ.A.Diabetic retinopathy. Natural history and treatment.Contemporary Dialysis1983; 4: 14–24.
39.
De VeneciaG.The eye in accelerated hypertension. Accelerate hypertension in patients with diabetic retinopathy. In: FriedmanE.A., L'EsperanceF.A., eds. Diabetic Renal-Retinal Syndrome.New York, Grune & Stratton, Inc., 1980, pp. 83–101.
40.
Diaz-BuxoJ.A., BurgessW.P., GreenmanM., ChandlerJ.T., FarmerC.D., WalkerP.J.Visual function in diabetic patients undergoing dialysis: comparison of peritoneal and hemodialysis.Int J Artif Organs1984; 7: 257–262.
41.
ShapiroF.L., ComtyC.M.Hemodialysis in diabetics - 1979 update. In: FriedmanE.A., L'EsperanceF.A., eds. Diabetic Renal-Retinal Syndrome.New York, Grune & Stratton, Inc., 1980, pp. 333–343.
42.
SjølieA.K.Blood pressure and retinopathy in early-onset Type I diabetic patients: an epidemiological study.Diabetic Nephropathy1985; 4: 41–42.
43.
Lauritzen T, Frost-Larsen K, Larsen HW, Deckert T, Keiding N, Nielsen G, and the Steno Study Group.Continuous subcutaneous insulin.Lancet1983; 1: 1445–1446.
44.
RandL.I., KrolewskiA.S., AielloL.M., WarramJ.H., BakerR.S., MakiT.Multiple factors in the prediction of proliferative diabetic retinopathy.NEJM1985; 313: 1433–1438.
45.
Early Treatment Diabetic Retinopathy Study Research Group.Photocoagulation for diabetic macular edema: Early Treatment Diabetic Retinapathy Study Report Number 1.Arch Ophthalmol1985; 103: 1796–1806.
46.
MachemerR., BuettnerH., NortonE.W.D., ParelJ.M.Vitrectomy: A pars plana approach.Trans Am Acad Ophthalmol Otolaryngol1971; 75: 813–820.
47.
ClementsR.S.Jr., BellD.S.H.Complications of diabetes. Prevalence, detection, current treatment, and prognosis.Am J Med79 (S-5A): 1985; 2–7.
48.
PirartJ.Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973.Diabetes Care1978; 1: 168–188.
49.
ServiceJ.F., DaubeJ.R., O'BrienP.C., ZimmermanB.R., SwansonC.J., BrennanM.D., DyckP.J.Effect of blood glucose control on peripheral nerve function in diabetic patients.Mayo Clin Proc1983; 58: 283–298.
50.
GreeneD.A., LattimerS.A.Recent advances in the therapy of diabetic peripheral neuropathy by means of an aldose reductase inhibitor.Am J Med79 (S-5A): 1985; 13–17.
51.
PfeiferM.A.Effects of glycemic control and aldose reductase inhibition on nerve conduction velocity.Am J Med79 (S-5A): 1985; 18–23.
52.
JaspanJ.B., HeroldK., BartkusC.Effects of sorbinil therapy in diabetic patients with painful peripheral neuropathy and autonomic neuropathy.Am J Med1985; 79(S-5A): 24–37.
53.
BlumenkrantzM.J., SaluskyI.B., SchmidtR.W.Managing the nutritional concerns of the patient undergoing peritoneal dialysis. In: NolphK.D., ed. Peritoneal Dialysis, 2nd edition.Boston, Martinus Nijhoff Publishers, 1985, pp. 345–401.
54.
BlumenkrantzM.J., KoppleJ.D.VA Cooperative Study Participants: Incidence of nutritional abnormalities in uremic patients entering dialysis therapy.Kidney Int1976; 10: 514.
55.
KoppleJ.D.Dietary requirements. In: MassryS.G., SellarsA., eds. Clinical Aspects of Uremia and Dialysis.Springfield, IL, Charles C. Thomas, 1976, p. 453.
56.
FürstP., AhlbergM.Principles of amino acid therapy in uremia.Am J Clinic Nutr1978; 31: 1744.
57.
KoppleJ.D., JonesM.Amino acid and protein metabolism in renal failure.Am J Clin Nutr.1978; 31: 1532.
58.
ThompsonN., StevensB., HumpheryT., AthensR.Comparison of trace elements in peritoneal dialysis, hemodialysis and uremia.Kidney Int1983; 25: 9–14.
59.
BlumenkrantzM.J., JonesM.R.Albumin metabolism in patients with chronic renal failure and those undergoing peritoneal or hemodialysis.Kidney Int1978; 14: 670.
60.
BlumenkrantzM.J., GahlG.M.Protein loss during peritoneal dialysis.Kidney Int1981; 19: 593–602.
61.
Diaz-BuxoJ.A.Intermittent, continuous ambulatory and continuous cycling peritoneal dialysis. In: NissensonA.R., FineR.N., GentileD.E., eds. Clinical Dialysis.Norwalk CT, Appleton-Century-Crofts, 1984, pp. 263–306.
62.
LegrainM.C.Diabetics with end-stage renal disease: “The best buy.”Diabetic Nephropathy1983; 2: 1–3.
63.
SutherlandE.D., FrydD.S., PetersC., FergusonR.M., NajarianJ.S.Current status of kidney transplant in uremic diabetics at the University of Minnesota. In: FriedmanE.A., L'EsperanceF.A., eds. Diabetic Renal-Retinal Syndrome 2, New York, Grune & Stratton, 1982, pp. 373–384.
